Management of phenylketonuria and hyperphenylalaninemia

Hyperphenylalaninemia (HPA) is the most frequently inherited disorder of a mi no acid metabolism (prevalence 1:10,000). In France, a nationwide neonatal screening was organized in 1978 to control its efficacy and patient follow-up. Phenylketonuria (PKU) was diagnosed in 81.6% of screened patients, the remaining affected with either non-PKU HPA 117.2%) or with cofactor deficiency (1.1 %). French guidelines were established to specify the minimal diagnosis procedures and optimal treatment of patients. A low-phenylalanine diet must be started within the first days of life for all newborns whose blood phenylalanine levels are above 10 mg/dL (600 mu mol/L). The dietary control must keep the phenylalanine levels between 2 and 5 mg/dL (120 and 300 mu mol/L) until 10 y of age. Thereafter, a progressive and controlled relaxation of the diet is allowed, keeping levels below 15 mg/dL until the end of adolescence and below 20 mg/c1L (1200 mu mol/L) in adulthood. A lifelong follow-up is recommended for PKU women to prevent for maternal PKU.